Adage Capital Partners’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,071,914
| Closed | -$4.45M | – | 978 |
|
|
2024
Q3 | $4.45M | Hold |
2,071,914
| – | – | 0.01% | 727 |
|
|
2024
Q2 | $10.7M | Hold |
2,071,914
| – | – | 0.02% | 590 |
|
|
2024
Q1 | $11.1M | Hold |
2,071,914
| – | – | 0.02% | 578 |
|
|
2023
Q4 | $16.1M | Buy |
2,071,914
+1,350,000
| +187% | +$10.5M | 0.03% | 488 |
|
|
2023
Q3 | $2.85M | Hold |
721,914
| – | – | 0.01% | 720 |
|
|
2023
Q2 | $2.27M | Hold |
721,914
| – | – | ﹤0.01% | 735 |
|
|
2023
Q1 | $1.93M | Hold |
721,914
| – | – | ﹤0.01% | 767 |
|
|
2022
Q4 | $2.59M | Hold |
721,914
| – | – | 0.01% | 800 |
|
|
2022
Q3 | $4.65M | Buy |
721,914
+531,914
| +280% | +$3.43M | 0.01% | 788 |
|
|
2022
Q2 | $1.83M | Hold |
190,000
| – | – | ﹤0.01% | 885 |
|
|
2022
Q1 | $2.26M | Hold |
190,000
| – | – | ﹤0.01% | 893 |
|
|
2021
Q4 | $6.19M | Buy |
190,000
+10,000
| +6% | +$326K | 0.01% | 792 |
|
|
2021
Q3 | $8.05M | Buy |
180,000
+94,770
| +111% | +$4.24M | 0.02% | 757 |
|
|
2021
Q2 | $4.65M | Buy |
+85,230
| New | +$4.65M | 0.01% | 834 |
|